2017
|
BioMarin Pharmaceutical
|
MSA risk assessment
How does the company assess the risks of modern slavery and trafficking in their supply chain?
Page 2, in the "Due Diligence" section: "BioMarin has not employed a third party to evaluate and address risks of human trafficking and slavery in its supply chain. However, any distribution used are background checked for due diligence purposes and reviewed by our compliance department before engaged as a partner."
Lan Hoang.....2017-10-29 20:21:14 UTC